This report reconsiders evidence and strategies toward the prevention of consequential late rectal toxicity after radiation therapy, with a focus on prostate cancer.
Novel clinical trial designs are encouraged, and these insights into the late effects of prostate radiation therapy have additional implications for late toxicity after cancer treatment for other tumors.
Written by:
Showalter TN, Wages N, Ohri N. Are you the author?
Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA; Division of Translational Research & Applied Statistics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA; Department of Radiation Oncology, Albert Einstein College of Medicine, New York, NY, USA.
Reference: Cancer Biol Ther. 2014 Feb 4;15(4).
PubMed Abstract
PMID: 24521697
UroToday.com Prostate Cancer Section
